Chinese startup DeepSeek unveils a cost-efficient method for training generative AI chatbots, prompting experts to re-examine investment strategies and the future of AI infrastructure.
Rising breast and cervical cancer registrations underscore the importance of early detection and access to quality medical care.
ASISA warns that reclassifying collective investment scheme portfolios as profit-making schemes will undermine years of established investment policy.
Nearly all business units report strong growth in new business volumes.
Reinvested income and strong interest-bearing portfolio performance led to net inflows of R85.82 billion in 2024.
The new SA Multi Asset SA High Equity category is expected to gain traction over time, despite slower uptake in the early stages.
A DebtBusters study provides interesting insights into how South Africans in different income bands prioritise their spending outside of debt repayments.
The Board of Healthcare Funders wants to see records that disclose whether President Cyril Ramaphosa disregarded constitutional concerns before signing the NHI Act into law.
The King Committee, in collaboration with the Institute of Directors in South Africa, has unveiled the draft King V Code for public comment.
With a focus on financial inclusion, digital transformation, and food security, SPEF II aims to drive impactful investments in underserved sectors.
Despite record-breaking global temperatures and escalating climate risks, most South African retirement funds lack climate policies – raising concerns about the long-term sustainability of their investments.
As South Africa’s decentralised finance market gains traction, the FSCA is exploring ways to balance innovation with consumer protection.
Lebohang Funeral Home left policyholders exposed by failing to secure underwriting, misleading clients about their coverage, and refusing to pay a valid funeral claim.
The decisions show that even thwarted attempts to breach confidentiality signal a critical lapse in integrity.
But the government cannot afford to set up an independent supply-side regulator as recommended by the Health Market Inquiry.
From impersonating financial institutions to AI-generated videos of trusted figures, fraudsters are exploiting technology and social networks to steal investors’ hard-earned money.
The complexities of prescription periods and cross-jurisdictional disputes can lead to significant insurance reserving and cost implications.
